{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:54:45Z","timestamp":1790456085308,"version":"4.1.0"},"reference-count":71,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1093\/brain\/aws055","type":"journal-article","created":{"date-parts":[[2012,3,26]],"date-time":"2012-03-26T21:35:21Z","timestamp":1332797721000},"page":"1900-1913","source":"Crossref","is-referenced-by-count":144,"title":["Cerebrospinal fluid biomarkers of central catecholamine deficiency in Parkinson\u2019s disease and other synucleinopathies"],"prefix":"10.1093","volume":"135","author":[{"given":"David S.","family":"Goldstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehonatan","family":"Sharabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,3,26]]},"reference":[{"issue":"Pt 12","key":"key\n\t\t\t\t20170425181757_aws055-B1","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1093\/brain\/120.12.2187","article-title":"Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease","volume":"120","author":"Antonini","year":"1997","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170425181757_aws055-B2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0304-3940(00)01623-2","article-title":"Pure autonomic failure in association with human alpha-synucleinopathy","volume":"296","author":"Arai","year":"2000","journal-title":"Neurosci Lett"},{"key":"key\n\t\t\t\t20170425181757_aws055-B3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF01252815","article-title":"Changes in dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC) levels in human cerebrospinal fluid after L-dopa and deprenyl administration","volume":"58","author":"Baraczka","year":"1983","journal-title":"J Neural Transm"},{"key":"key\n\t\t\t\t20170425181757_aws055-B4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson's disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res"},{"key":"key\n\t\t\t\t20170425181757_aws055-B5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0022-510X(93)90316-Q","article-title":"Monoamines and their metabolites in plasma and lumbar cerebrospinal fluid of Chinese patients with Parkinson's disease","volume":"116","author":"Chia","year":"1993","journal-title":"J Neurol Sci"},{"key":"key\n\t\t\t\t20170425181757_aws055-B6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0022-510X(93)90316-Q","article-title":"Monoamines and their metabolites in plasma and lumbar cerebrospinal fluid of Chinese patients with Parkinson's disease","volume":"116","author":"Chia","year":"1993","journal-title":"J Neurol Sci"},{"key":"key\n\t\t\t\t20170425181757_aws055-B7","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.1971.03190260019005","article-title":"Levodopa in the treatment of Parkinsonism","volume":"218","author":"Cotzias","year":"1971","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170425181757_aws055-B8","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1001\/archneur.65.8.1074","article-title":"Incidental Lewy body disease and preclinical Parkinson disease","volume":"65","author":"DelleDonne","year":"2008","journal-title":"Arch Neurol"},{"key":"key\n\t\t\t\t20170425181757_aws055-B9","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1750-3639.1999.tb00553.x","article-title":"Multiple system atrophy: a sporadic synucleinopathy","volume":"9","author":"Dickson","year":"1999","journal-title":"Brain Pathol"},{"key":"key\n\t\t\t\t20170425181757_aws055-B10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1469-1809.2009.00560.x","article-title":"Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease","volume":"74","author":"Edwards","year":"2010","journal-title":"Ann Hum Genet"},{"key":"key\n\t\t\t\t20170425181757_aws055-B11","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/BF01485901","article-title":"[Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system.]","volume":"38","author":"Ehringer","year":"1960","journal-title":"Wien Klin Wochenschr"},{"key":"key\n\t\t\t\t20170425181757_aws055-B12","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1093\/clinchem\/32.11.2030","article-title":"Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase","volume":"32","author":"Eisenhofer","year":"1986","journal-title":"Clin Chem"},{"key":"key\n\t\t\t\t20170425181757_aws055-B13","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1124\/pr.56.3.1","article-title":"Catecholamine metabolism: a contemporary view with implications for physiology and medicine","volume":"56","author":"Eisenhofer","year":"2004","journal-title":"Pharmacol Rev"},{"key":"key\n\t\t\t\t20170425181757_aws055-B14","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1096\/fj.03-1449com","article-title":"Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease","volume":"20","author":"El-Agnaf","year":"2006","journal-title":"FASEB J"},{"key":"key\n\t\t\t\t20170425181757_aws055-B15","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1600-0404.1995.tb01023.x","article-title":"CSF and plasma concentrations of free norepinephrine, dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC), 3,4-dihydroxyphenylalanine (DOPA), and epinephrine in Parkinson's disease","volume":"92","author":"Eldrup","year":"1995","journal-title":"Acta Neurol Scand"},{"key":"key\n\t\t\t\t20170425181757_aws055-B16","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.2042-7158.1987.tb06973.x","article-title":"Probenecid-induced accumulation of 5-hydroxyindoleacetic acid and homovanillic acid in rat brain","volume":"39","author":"Emanuelsson","year":"1987","journal-title":"J Pharm Pharmacol"},{"key":"key\n\t\t\t\t20170425181757_aws055-B17","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1023\/A:1024255208563","article-title":"Amino acids and biogenic amines in cerebrospinal fluid of patients with Parkinson's disease","volume":"28","author":"Engelborghs","year":"2003","journal-title":"Neurochem Res"},{"key":"key\n\t\t\t\t20170425181757_aws055-B18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.neuro.2006.07.018","article-title":"Inhibition of the oxidative metabolism of 3,4-dihydroxyphenylacetaldehyde, a reactive intermediate of dopamine metabolism, by 4-hydroxy-2-nonenal","volume":"28","author":"Florang","year":"2007","journal-title":"Neurotoxicology"},{"key":"key\n\t\t\t\t20170425181757_aws055-B19","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1176\/jnp.2.1.114","article-title":"On the involvement of the locus ceruleus in Parkinson's disease","volume":"2","author":"Freed","year":"1990","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"key\n\t\t\t\t20170425181757_aws055-B20","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.nbd.2003.09.001","article-title":"ALDH1 mRNA: presence in human dopamine neurons and decreases in substantia nigra in Parkinson's disease and in the ventral tegmental area in schizophrenia","volume":"14","author":"Galter","year":"2003","journal-title":"Neurobiol Dis"},{"key":"key\n\t\t\t\t20170425181757_aws055-B21","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.parkreldis.2008.01.010","article-title":"Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy","volume":"14","author":"Goldstein","year":"2008","journal-title":"Parkinsonism Relat Disord"},{"key":"key\n\t\t\t\t20170425181757_aws055-B22","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1212\/WNL.58.8.1247","article-title":"Orthostatic hypotension from sympathetic denervation in Parkinson\u2019s disease","volume":"58","author":"Goldstein","year":"2002","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170425181757_aws055-B23","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1172\/JCI45803","article-title":"Intra-neuronal vesicular uptake of catecholamines is decreased in patients with Lewy body diseases","volume":"121","author":"Goldstein","year":"2011","journal-title":"J Clin Inv"},{"key":"key\n\t\t\t\t20170425181757_aws055-B24","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1042\/CS20020315","article-title":"Cerebrospinal fluid levels of catechols in patients with neurogenic orthostatic hypotension","volume":"104","author":"Goldstein","year":"2003","journal-title":"Clin Sci"},{"key":"key\n\t\t\t\t20170425181757_aws055-B25","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s10286-008-0457-0","article-title":"Central dopamine deficiency in pure autonomic failure","volume":"18","author":"Goldstein","year":"2008","journal-title":"Clin Auton Res"},{"key":"key\n\t\t\t\t20170425181757_aws055-B71","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/ana.410260410","article-title":"Patterns of plasma levels of catechols in neurogenic orthostatic hypotension","volume":"26","author":"Goldstein","year":"1989","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170425181757_aws055-B26","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1468-1331.2010.03246.x","article-title":"Catechols in post-mortem brain of patients with Parkinson disease","volume":"18","author":"Goldstein","year":"2011","journal-title":"Eur J Neurol"},{"key":"key\n\t\t\t\t20170425181757_aws055-B27","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1210\/jcem-64-4-856","article-title":"Neuronal source of plasma dihydroxyphenylalanine","volume":"64","author":"Goldstein","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20170425181757_aws055-B28","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.3949\/ccjm.74.Suppl_1.S91","article-title":"Cardiac denervation in patients with Parkinson disease","volume":"74","author":"Goldstein","year":"2007","journal-title":"Cleve Clin J Med"},{"key":"key\n\t\t\t\t20170425181757_aws055-B29","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1474-4422(03)00555-6","article-title":"Dysautonomia in Parkinson's disease: neurocardiological abnormalities","volume":"2","author":"Goldstein","year":"2003","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t20170425181757_aws055-B30","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s10286-006-0317-8","article-title":"Orthostatic hypotension as an early finding in Parkinson disease","volume":"16","author":"Goldstein","year":"2006","journal-title":"Clin Auton Res"},{"key":"key\n\t\t\t\t20170425181757_aws055-B31","first-page":"13","article-title":"Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system","volume":"41","author":"Gonzalez-Quevedo","year":"1993","journal-title":"Bol Estud Med Biol"},{"key":"key\n\t\t\t\t20170425181757_aws055-B32","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ana.410270405","article-title":"Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease","volume":"27","author":"Halliday","year":"1990","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170425181757_aws055-B33","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0378-4347(93)E0430-X","article-title":"Improved assay for plasma dihydroxyphenylacetic acid and other catechols using high-performance liquid chromatography with electrochemical detection","volume":"653","author":"Holmes","year":"1994","journal-title":"J Chromatogr B Biomed Appl"},{"key":"key\n\t\t\t\t20170425181757_aws055-B34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/jcbfm.1993.8","article-title":"6-[18F]fluoro-L-dopa metabolism in living human brain: a comparison of six analytical methods","volume":"13","author":"Hoshi","year":"1993","journal-title":"J Cereb Blood Flow Metab"},{"key":"key\n\t\t\t\t20170425181757_aws055-B35","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1002\/mds.10557","article-title":"Neuropathological spectrum of synucleinopathies","volume":"18","author":"Jellinger","year":"2003","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170425181757_aws055-B36","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1021\/tx800405v","article-title":"Products of oxidative stress inhibit aldehyde oxidation and reduction pathways in dopamine catabolism yielding elevated levels of a reactive intermediate","volume":"22","author":"Jinsmaa","year":"2009","journal-title":"Chem Res Toxicol"},{"key":"key\n\t\t\t\t20170425181757_aws055-B37","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2967\/jnumed.108.061572","article-title":"Simple ratio analysis of 18\u2009F-fluorodopa uptake in striatal subregions separates patients with early Parkinson disease from healthy controls","volume":"50","author":"Jokinen","year":"2009","journal-title":"J Nucl Med"},{"key":"key\n\t\t\t\t20170425181757_aws055-B38","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1212\/WNL.0b013e3181d26982","article-title":"Pure autonomic failure: a restricted Lewy body synucleinopathy or early Parkinson disease?","volume":"74","author":"Kaufmann","year":"2010","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170425181757_aws055-B39","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF02291236","article-title":"Consensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy","volume":"6","author":"Kaufmann","year":"1996","journal-title":"Clin Auton Res"},{"key":"key\n\t\t\t\t20170425181757_aws055-B40","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1001\/archneur.1984.04210080020007","article-title":"Cerebellar norepinephrine in patients with Parkinson's disease and control subjects","volume":"41","author":"Kish","year":"1984","journal-title":"Arch Neurol"},{"key":"key\n\t\t\t\t20170425181757_aws055-B41","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/BF01271258","article-title":"Depression in Parkinson's disease: biogenic amines in CSF of \u201cde novo\u201d patients","volume":"103","author":"Kuhn","year":"1996","journal-title":"J Neural Transm"},{"key":"key\n\t\t\t\t20170425181757_aws055-B42","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0022-3565(25)11162-2","article-title":"Plasma dopa responses during stress: dependence on sympathoneural activity and tyrosine hydroxylation","volume":"261","author":"Kvetnansky","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t20170425181757_aws055-B43","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1111\/j.1471-4159.1992.tb10977.x","article-title":"Effects of handling or immobilization on plasma levels of 3,4-dihydroxyphenylalanine, catecholamines, and metabolites in rats","volume":"58","author":"Kvetnansky","year":"1992","journal-title":"J Neurochem"},{"key":"key\n\t\t\t\t20170425181757_aws055-B44","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1212\/WNL.42.11.2111","article-title":"Markers of dopamine metabolism in Parkinson's disease. The Parkinson Study Group","volume":"42","author":"LeWitt","year":"1992","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170425181757_aws055-B45","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0022-3565(25)30363-0","article-title":"The neurochemistry of Parkinson's disease: effect of L-dopa therapy","volume":"195","author":"Lloyd","year":"1975","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t20170425181757_aws055-B46","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF02252962","article-title":"Markers of dopamine depletion and compensatory response in striatum and cerebrospinal fluid","volume":"9","author":"Loeffler","year":"1995","journal-title":"J Neural Transm Park Dis Dement Sect"},{"key":"key\n\t\t\t\t20170425181757_aws055-B47","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1196\/annals.1344.031","article-title":"Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70","volume":"1053","author":"Mandel","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"key\n\t\t\t\t20170425181757_aws055-B48","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S1474-4422(11)70014-X","article-title":"alpha-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study","volume":"10","author":"Mollenhauer","year":"2011","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t20170425181757_aws055-B49","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00401-006-0160-y","article-title":"Degeneration of cardiac sympathetic nerve can occur in multiple system atrophy","volume":"113","author":"Orimo","year":"2007","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20170425181757_aws055-B50","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1136\/jnnp.73.6.776","article-title":"Sympathetic cardiac denervation in Parkinson's disease and pure autonomic failure but not in multiple system atrophy","volume":"73","author":"Orimo","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key\n\t\t\t\t20170425181757_aws055-B51","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1212\/WNL.57.6.1140","article-title":"Different histopathology accounting for a decrease in myocardial MIBG uptake in PD and MSA","volume":"57","author":"Orimo","year":"2001","journal-title":"Neurology"},{"issue":"Pt 3","key":"key\n\t\t\t\t20170425181757_aws055-B52","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/brain\/awm302","article-title":"Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease","volume":"131","author":"Orimo","year":"2008","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170425181757_aws055-B53","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0160-5402(82)90073-0","article-title":"Value of monoamine metabolite determinations in CSF as an index of their concentrations in rat brain following various pharmacological manipulations","volume":"8","author":"Palfreyman","year":"1982","journal-title":"J Pharmacol Methods"},{"key":"key\n\t\t\t\t20170425181757_aws055-B54","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"key\n\t\t\t\t20170425181757_aws055-B55","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1017\/S0317167100031814","article-title":"Accuracy of clinical diagnosis in parkinsonism\u2013a prospective study","volume":"18","author":"Rajput","year":"1991","journal-title":"Can J Neurol Sci"},{"key":"key\n\t\t\t\t20170425181757_aws055-B56","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0006-3223(99)00008-6","article-title":"Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer's disease","volume":"46","author":"Raskind","year":"1999","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t20170425181757_aws055-B57","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1600-0773.1984.tb01967.x","article-title":"Determination of conjugated dopamine in cerebrospinal fluid from humans and non-human primates with high performance liquid chromatography using electrochemical detection","volume":"55","author":"Scheinin","year":"1984","journal-title":"Acta Pharmacol Toxicol"},{"key":"key\n\t\t\t\t20170425181757_aws055-B58","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/ana.22311","article-title":"Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression","volume":"69","author":"Shi","year":"2011","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170425181757_aws055-B59","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1212\/WNL.0b013e3181cff6d5","article-title":"alpha-synuclein accumulation in skin nerve fibers revealed by skin biopsy in pure autonomic failure","volume":"74","author":"Shishido","year":"2010","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170425181757_aws055-B60","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/00004647-200202000-00011","article-title":"Increase in dopamine turnover occurs early in Parkinson's disease: evidence from a new modeling approach to PET 18\u2009F-fluorodopa data","volume":"22","author":"Sossi","year":"2002","journal-title":"J Cereb Blood Flow Metab"},{"key":"key\n\t\t\t\t20170425181757_aws055-B61","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170425181757_aws055-B62","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.parkreldis.2011.04.016","article-title":"Prevalence of orthostatic hypotension in Parkinson's disease: A systematic review and meta-analysis","volume":"17","author":"Velseboer","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"key":"key\n\t\t\t\t20170425181757_aws055-B63","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0304-3940(98)00407-8","article-title":"Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy","volume":"249","author":"Wakabayashi","year":"1998","journal-title":"Neurosci Lett"},{"key":"key\n\t\t\t\t20170425181757_aws055-B64","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1126\/science.129.3357.1226","article-title":"Blood-brain barrier for adrenaline","volume":"129","author":"Weil-Malherbe","year":"1959","journal-title":"Science"},{"key":"key\n\t\t\t\t20170425181757_aws055-B65","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1477-5956-6-8","article-title":"Proteome analysis of human substantia nigra in Parkinson's disease","volume":"6","author":"Werner","year":"2008","journal-title":"Proteome Sci"},{"key":"key\n\t\t\t\t20170425181757_aws055-B66","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archneur.60.3.337","article-title":"Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases","volume":"60","author":"Zarow","year":"2003","journal-title":"Arch Neurol"},{"key":"key\n\t\t\t\t20170425181757_aws055-B67","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1309\/W01Y0B808EMEH12L","article-title":"CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases","volume":"129","author":"Zhang","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t20170425181757_aws055-B68","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM197702102960601","article-title":"The sympathetic-nervous-system defect in primary orthostatic hypotension","volume":"296","author":"Ziegler","year":"1977","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170425181757_aws055-B69","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/0006-3223(86)90328-8","article-title":"Cerebrospinal fluid levels of angiotensin-converting enzyme, acetylcholinesterase, and dopamine metabolites in dementia associated with Alzheimer's disease and Parkinson's disease: a correlative study","volume":"21","author":"Zubenko","year":"1986","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t20170425181757_aws055-B70","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1212\/WNL.43.5.986","article-title":"The locus ceruleus and dementia in Parkinson's disease","volume":"43","author":"Zweig","year":"1993","journal-title":"Neurology"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/135\/6\/1900\/13796907\/aws055.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T21:40:42Z","timestamp":1742766042000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article-lookup\/doi\/10.1093\/brain\/aws055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,26]]},"references-count":71,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2012,3,26]]},"published-print":{"date-parts":[[2012,6]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/aws055","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717957722.793462126","asserted-by":"object"}]},"ISSN":["1460-2156","0006-8950"],"issn-type":[{"value":"1460-2156","type":"electronic"},{"value":"0006-8950","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3,26]]}}}